_id
6915eb16bc934aba376b1cae
Ticker
QNTM
Name
Quantum BioPharma Ltd.
Exchange
NASDAQ
Address
55 University Avenue, Toronto, ON, Canada, M5J 2H7
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.quantumbiopharma.com
Description
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.
Last Close
6.98
Volume
90005
Current Price
7.43
Change
0.22
Last Updated
2026-01-06T09:53:52.594Z
Image
-
Ipo Date
2018-06-08T00:00:00.000Z
Market Cap
26939270
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.58925
Sentiment Sources
4
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
4747600
Operating Income
-4747600
Interest Expense
105075
Pretax Income
-4747600
Net Income
-5319029
Eps
-1.3993206268311889
Dividends Per Share
-
Shares Outstanding
3842935
Income Tax Expense
-
EBITDA
-4497189
Operating Margin
-
Total Other Income Expense Net
-84750
Cash
445944
Short Term Investments
636761
Receivables
2936366
Inventories
77622
Total Current Assets
9343236
Property Plant Equipment
190755
Total Assets
14153228
Payables
2609475
Short Term Debt
2557098
Long Term Debt
-
Total Liabilities
6646480
Equity
8652043
Bs_currency_symbol
USD
Depreciation
145336
Change In Working Capital
2131264
Cash From Operations
-1721476
Capital Expenditures
0
Cash From Investing
408419
Cash From Financing
261425
Net Change In Cash
-1051632
Cf_currency_symbol
USD
PE
-
PB
3.2642639351191387
ROE
-61.47714476222552
ROA
-37.5817375371894
FCF
-1721476
Fcf Percent
-
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
2
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
4747600
Quarters > 0 > income Statement > operating Income
-4747600
Quarters > 0 > income Statement > interest Expense
105075
Quarters > 0 > income Statement > pretax Income
-4747600
Quarters > 0 > income Statement > net Income
-5319029
Quarters > 0 > income Statement > eps
-1.3993206268311889
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3801151
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4497189
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-84750
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
445944
Quarters > 0 > balance Sheet > short Term Investments
636761
Quarters > 0 > balance Sheet > receivables
2936366
Quarters > 0 > balance Sheet > inventories
77622
Quarters > 0 > balance Sheet > total Current Assets
9343236
Quarters > 0 > balance Sheet > property Plant Equipment
190755
Quarters > 0 > balance Sheet > total Assets
14153228
Quarters > 0 > balance Sheet > payables
2609475
Quarters > 0 > balance Sheet > short Term Debt
2557098
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6646480
Quarters > 0 > balance Sheet > equity
8652043
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-4747600
Quarters > 0 > cash Flow > depreciation
145336
Quarters > 0 > cash Flow > change In Working Capital
2131264
Quarters > 0 > cash Flow > cash From Operations
-1721476
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
408419
Quarters > 0 > cash Flow > cash From Financing
261425
Quarters > 0 > cash Flow > net Change In Cash
-1051632
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.3993206268311889
Quarters > 0 > ratios > PB
3.2642639351191387
Quarters > 0 > ratios > ROE
-61.47714476222552
Quarters > 0 > ratios > ROA
-37.5817375371894
Quarters > 0 > ratios > FCF
-1721476
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
4853439
Quarters > 1 > income Statement > operating Income
-4853439
Quarters > 1 > income Statement > interest Expense
235573
Quarters > 1 > income Statement > pretax Income
-9766327
Quarters > 1 > income Statement > net Income
-9253067
Quarters > 1 > income Statement > eps
-3.0629101904829685
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3021005
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-9389371
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-4912888
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1497576
Quarters > 1 > balance Sheet > short Term Investments
30786
Quarters > 1 > balance Sheet > receivables
3232058
Quarters > 1 > balance Sheet > inventories
76869
Quarters > 1 > balance Sheet > total Current Assets
10343591
Quarters > 1 > balance Sheet > property Plant Equipment
228170
Quarters > 1 > balance Sheet > total Assets
15297031
Quarters > 1 > balance Sheet > payables
1871197
Quarters > 1 > balance Sheet > short Term Debt
2265140
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
13249998
Quarters > 1 > balance Sheet > equity
3763757
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-9766327
Quarters > 1 > cash Flow > depreciation
141383
Quarters > 1 > cash Flow > change In Working Capital
-1082617
Quarters > 1 > cash Flow > cash From Operations
-1949095
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-1361330
Quarters > 1 > cash Flow > cash From Financing
1289688
Quarters > 1 > cash Flow > net Change In Cash
-2020737
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-3.0629101904829685
Quarters > 1 > ratios > PB
5.963739728680678
Quarters > 1 > ratios > ROE
-245.84655704393242
Quarters > 1 > ratios > ROA
-60.48930017857713
Quarters > 1 > ratios > FCF
-1949095
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
20
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
129298
Quarters > 2 > income Statement > gross Profit
-129298
Quarters > 2 > income Statement > operating Expenses
3397423
Quarters > 2 > income Statement > operating Income
-3397423
Quarters > 2 > income Statement > interest Expense
350616
Quarters > 2 > income Statement > pretax Income
-8739881
Quarters > 2 > income Statement > net Income
-8576723
Quarters > 2 > income Statement > eps
-7.54380951375732
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1136922
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-8259575
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-5342458
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3518313
Quarters > 2 > balance Sheet > short Term Investments
20868
Quarters > 2 > balance Sheet > receivables
3411994
Quarters > 2 > balance Sheet > inventories
93856
Quarters > 2 > balance Sheet > total Current Assets
9931779
Quarters > 2 > balance Sheet > property Plant Equipment
109319
Quarters > 2 > balance Sheet > total Assets
14873469
Quarters > 2 > balance Sheet > payables
1321102
Quarters > 2 > balance Sheet > short Term Debt
1280207
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10344361
Quarters > 2 > balance Sheet > equity
5732572
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-8739881
Quarters > 2 > cash Flow > depreciation
129690
Quarters > 2 > cash Flow > change In Working Capital
284207
Quarters > 2 > cash Flow > cash From Operations
-4260843
Quarters > 2 > cash Flow > capital Expenditures
3
Quarters > 2 > cash Flow > cash From Investing
-1350208
Quarters > 2 > cash Flow > cash From Financing
3133492
Quarters > 2 > cash Flow > net Change In Cash
-2477559
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-7.54380951375732
Quarters > 2 > ratios > PB
1.4735672678860379
Quarters > 2 > ratios > ROE
-149.61387314455013
Quarters > 2 > ratios > ROA
-57.66457710706224
Quarters > 2 > ratios > FCF
-4260846
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
33
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
112803
Quarters > 3 > income Statement > gross Profit
-112803
Quarters > 3 > income Statement > operating Expenses
6241228
Quarters > 3 > income Statement > operating Income
-6241228
Quarters > 3 > income Statement > interest Expense
16435
Quarters > 3 > income Statement > pretax Income
-5456278
Quarters > 3 > income Statement > net Income
-5360263
Quarters > 3 > income Statement > eps
-5.217384914126642
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1027385
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5327040
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
784950
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
5995872
Quarters > 3 > balance Sheet > short Term Investments
1202349
Quarters > 3 > balance Sheet > receivables
3807018
Quarters > 3 > balance Sheet > inventories
117242
Quarters > 3 > balance Sheet > total Current Assets
12052747
Quarters > 3 > balance Sheet > property Plant Equipment
130382
Quarters > 3 > balance Sheet > total Assets
17119224
Quarters > 3 > balance Sheet > payables
3254838
Quarters > 3 > balance Sheet > short Term Debt
824922
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6678992
Quarters > 3 > balance Sheet > equity
11480538
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-5456278
Quarters > 3 > cash Flow > depreciation
112803
Quarters > 3 > cash Flow > change In Working Capital
7370083
Quarters > 3 > cash Flow > cash From Operations
-835762
Quarters > 3 > cash Flow > capital Expenditures
1.74
Quarters > 3 > cash Flow > cash From Investing
1243865
Quarters > 3 > cash Flow > cash From Financing
2467543
Quarters > 3 > cash Flow > net Change In Cash
2875646
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-5.217384914126642
Quarters > 3 > ratios > PB
0.6649052988631717
Quarters > 3 > ratios > ROE
-46.68999832586243
Quarters > 3 > ratios > ROA
-31.311366683443126
Quarters > 3 > ratios > FCF
-835763.74
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
490571
Annuals > 0 > income Statement > gross Profit
-490571
Annuals > 0 > income Statement > operating Expenses
16136260
Annuals > 0 > income Statement > operating Income
-16136260
Annuals > 0 > income Statement > interest Expense
47577
Annuals > 0 > income Statement > pretax Income
-14915529
Annuals > 0 > income Statement > net Income
-14202724
Annuals > 0 > income Statement > eps
-12.492258923655273
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1136922
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-14377381
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1220731
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5995872
Annuals > 0 > balance Sheet > short Term Investments
1202349
Annuals > 0 > balance Sheet > receivables
3807018
Annuals > 0 > balance Sheet > inventories
117242
Annuals > 0 > balance Sheet > total Current Assets
12052747
Annuals > 0 > balance Sheet > property Plant Equipment
130382
Annuals > 0 > balance Sheet > total Assets
17119224
Annuals > 0 > balance Sheet > payables
3254838
Annuals > 0 > balance Sheet > short Term Debt
824922
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6678992
Annuals > 0 > balance Sheet > equity
11480538
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-14915529
Annuals > 0 > cash Flow > depreciation
490571
Annuals > 0 > cash Flow > change In Working Capital
9756632
Annuals > 0 > cash Flow > cash From Operations
-6876479
Annuals > 0 > cash Flow > capital Expenditures
1.43
Annuals > 0 > cash Flow > cash From Investing
-1503559
Annuals > 0 > cash Flow > cash From Financing
11618870
Annuals > 0 > cash Flow > net Change In Cash
3238832
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-12.492258923655273
Annuals > 0 > ratios > PB
0.7159896217407234
Annuals > 0 > ratios > ROE
-123.71131039329342
Annuals > 0 > ratios > ROA
-82.96359694808596
Annuals > 0 > ratios > FCF
-6876480.43
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
23789498
Annuals > 1 > income Statement > operating Income
-23789498
Annuals > 1 > income Statement > interest Expense
299
Annuals > 1 > income Statement > pretax Income
-18230588
Annuals > 1 > income Statement > net Income
-17902179
Annuals > 1 > income Statement > eps
-29.393321796353703
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
609056
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-15723973
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
5558910
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2757040
Annuals > 1 > balance Sheet > short Term Investments
756100
Annuals > 1 > balance Sheet > receivables
7416752
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
11085305
Annuals > 1 > balance Sheet > property Plant Equipment
120421
Annuals > 1 > balance Sheet > total Assets
17474828
Annuals > 1 > balance Sheet > payables
3240658
Annuals > 1 > balance Sheet > short Term Debt
339199
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4565566
Annuals > 1 > balance Sheet > equity
13236763
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-18230588
Annuals > 1 > cash Flow > depreciation
2506316
Annuals > 1 > cash Flow > change In Working Capital
1637800
Annuals > 1 > cash Flow > cash From Operations
-10827264
Annuals > 1 > cash Flow > capital Expenditures
2.2
Annuals > 1 > cash Flow > cash From Investing
-269579
Annuals > 1 > cash Flow > cash From Financing
-3126589
Annuals > 1 > cash Flow > net Change In Cash
-14223432
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-29.393321796353703
Annuals > 1 > ratios > PB
0.3326700704696458
Annuals > 1 > ratios > ROE
-135.24589810968135
Annuals > 1 > ratios > ROA
-102.44552335507966
Annuals > 1 > ratios > FCF
-10827266.2
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
27429611
Annuals > 2 > income Statement > operating Income
-27429611
Annuals > 2 > income Statement > interest Expense
48822
Annuals > 2 > income Statement > pretax Income
-26703662
Annuals > 2 > income Statement > net Income
-23606828
Annuals > 2 > income Statement > eps
-39.61661537015718
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
595882
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-22117425
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
725949
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
16980472
Annuals > 2 > balance Sheet > short Term Investments
23188
Annuals > 2 > balance Sheet > receivables
374377
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
17850174
Annuals > 2 > balance Sheet > property Plant Equipment
260925
Annuals > 2 > balance Sheet > total Assets
38410656
Annuals > 2 > balance Sheet > payables
2760002
Annuals > 2 > balance Sheet > short Term Debt
478419
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7868436
Annuals > 2 > balance Sheet > equity
30542220
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-26703662
Annuals > 2 > cash Flow > depreciation
4534586
Annuals > 2 > cash Flow > change In Working Capital
-7120329
Annuals > 2 > cash Flow > cash From Operations
-28333273
Annuals > 2 > cash Flow > capital Expenditures
363958
Annuals > 2 > cash Flow > cash From Investing
12123408
Annuals > 2 > cash Flow > cash From Financing
-2069308
Annuals > 2 > cash Flow > net Change In Cash
-18279173
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-39.61661537015718
Annuals > 2 > ratios > PB
0.14105807829293351
Annuals > 2 > ratios > ROE
-77.29244305096356
Annuals > 2 > ratios > ROA
-61.45905969426817
Annuals > 2 > ratios > FCF
-28697231
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
33743660
Annuals > 3 > income Statement > operating Income
-33743660
Annuals > 3 > income Statement > interest Expense
69404
Annuals > 3 > income Statement > pretax Income
-33937956
Annuals > 3 > income Statement > net Income
-35285429
Annuals > 3 > income Statement > eps
-65.63290105614023
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
537618
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-29823029
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-194296
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
35259645
Annuals > 3 > balance Sheet > short Term Investments
158036
Annuals > 3 > balance Sheet > receivables
500964
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
45932845
Annuals > 3 > balance Sheet > property Plant Equipment
168307
Annuals > 3 > balance Sheet > total Assets
62963117
Annuals > 3 > balance Sheet > payables
2995726
Annuals > 3 > balance Sheet > short Term Debt
424860
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8832079
Annuals > 3 > balance Sheet > equity
54131038
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-33937956
Annuals > 3 > cash Flow > depreciation
4045523
Annuals > 3 > cash Flow > change In Working Capital
2888733
Annuals > 3 > cash Flow > cash From Operations
-20746223
Annuals > 3 > cash Flow > capital Expenditures
500000
Annuals > 3 > cash Flow > cash From Investing
268964
Annuals > 3 > cash Flow > cash From Financing
38212082
Annuals > 3 > cash Flow > net Change In Cash
17734823
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-65.63290105614023
Annuals > 3 > ratios > PB
0.07180682809001372
Annuals > 3 > ratios > ROE
-65.18520668308632
Annuals > 3 > ratios > ROA
-56.041426602180444
Annuals > 3 > ratios > FCF
-21246223
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-1.3993206268311889
Valuation > metrics > PB
3.2642639351191387
Valuation > final Score
47.357360648808616
Valuation > verdict
8.8% Overvalued
Profitability > metrics > ROE
-61.47714476222552
Profitability > metrics > ROA
-56.92919455315053
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7681977539871219
Risk > metrics > Interest Coverage
-45.182964549131576
Risk > final Score
-133
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.8084010426253534
Liquidity > metrics > Quick Ratio
1.7933771573536268
Liquidity > final Score
95
Liquidity > verdict
Great
Prev Valuations > 0
20.36260271319322
Prev Valuations > 1
80
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-76
Prev Risks > 1
-9
Prev Risks > 2
-1471
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:27:21.928Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.77
Earnings History > 0 > eps Estimate
-3.7
Earnings History > 0 > eps Difference
1.93
Earnings History > 0 > surprise Percent
52.1622
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-3.06
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-3.06
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-2.3311
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-28
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.7
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-4.1697
Earnings History > 4 > eps Estimate
-3.9
Earnings History > 4 > eps Difference
-0.2697
Earnings History > 4 > surprise Percent
-6.9154
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-5.2
Earnings History > 5 > eps Estimate
-3.9
Earnings History > 5 > eps Difference
-1.3
Earnings History > 5 > surprise Percent
-33.3333
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-3.25
Earnings History > 6 > eps Estimate
-3.25
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-29
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-9.75
Earnings History > 7 > eps Estimate
-0.14
Earnings History > 7 > eps Difference
-9.61
Earnings History > 7 > surprise Percent
-6864.2857
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-15
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.03
Earnings History > 8 > eps Estimate
-0.14
Earnings History > 8 > eps Difference
0.11
Earnings History > 8 > surprise Percent
78.5714
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-11
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.14
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-18
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-16.6119
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-11
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-12.1284
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-7.4734
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-04-01
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-9.5965
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-30
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-10.55
Earnings History > 15 > eps Estimate
-68.25
Earnings History > 15 > eps Difference
57.7
Earnings History > 15 > surprise Percent
84.5421
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.15
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.35
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-20
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-24.0183
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-17
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-10.5495
Earnings History > 19 > eps Estimate
-1.06
Earnings History > 19 > eps Difference
-9.4895
Earnings History > 19 > surprise Percent
-895.2358
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-84.5
Earnings History > 20 > eps Estimate
-46.48
Earnings History > 20 > eps Difference
-38.02
Earnings History > 20 > surprise Percent
-81.7986
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-07
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.5037
Earnings History > 21 > eps Estimate
-72.1501
Earnings History > 21 > eps Difference
71.6464
Earnings History > 21 > surprise Percent
99.3019
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-15
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-73.7902
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-02
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-177.45
Earnings History > 23 > eps Estimate
-92.3
Earnings History > 23 > eps Difference
-85.15
Earnings History > 23 > surprise Percent
-92.2535
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-29
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-108.3455
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-28
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-98.7372
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-03-31
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-16.2756
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2018-12-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-150.2935
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-09-30
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
29.1238
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-06-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
38.1761
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AChipmakers Recap: Is QNTM impacted by rising rates - 2025 Price Momentum & Free Community Consensus Stock Picks baoquankhu1.vn
Read more →CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM Chartmill
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Quantum BioPharma Ltd.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.77
EPS Estimate
-3.7
EPS Difference
1.93
Surprise Percent
52.1622%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.